Lindbrook Capital’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $9.2K | Sell |
51
-7
| -12% | -$1.26K | ﹤0.01% | 1692 |
|
|
2024
Q4 | $9.09K | Sell |
58
-20
| -26% | -$3.13K | ﹤0.01% | 1700 |
|
|
2024
Q3 | $14.2K | Buy |
78
+3
| +4% | +$546 | ﹤0.01% | 1492 |
|
|
2024
Q2 | $13.8K | Buy |
75
+38
| +103% | +$6.98K | ﹤0.01% | 1455 |
|
|
2024
Q1 | $6.58K | Buy |
37
+1
| +3% | +$178 | ﹤0.01% | 1772 |
|
|
2023
Q4 | $4.47K | Sell |
36
-2
| -5% | -$248 | ﹤0.01% | 1943 |
|
|
2023
Q3 | $4.41K | Buy |
38
+6
| +19% | +$696 | ﹤0.01% | 1824 |
|
|
2023
Q2 | $3.76K | Hold |
32
| – | – | ﹤0.01% | 1926 |
|
|
2023
Q1 | $2.56K | Sell |
32
-19
| -37% | -$1.52K | ﹤0.01% | 2140 |
|
|
2022
Q4 | $4.04K | Buy |
51
+41
| +410% | +$3.25K | ﹤0.01% | 1929 |
|
|
2022
Q3 | $1K | Buy |
10
+5
| +100% | +$500 | ﹤0.01% | 2380 |
|
|
2022
Q2 | $0 | Sell |
5
-7
| -58% | – | ﹤0.01% | 2646 |
|
|
2022
Q1 | $1K | Buy |
+12
| New | +$1K | ﹤0.01% | 2274 |
|
|
2020
Q2 | – | Sell |
-25
| Closed | -$1K | – | 1813 |
|
|
2020
Q1 | $1K | Buy |
25
+6
| +32% | +$240 | ﹤0.01% | 1489 |
|
|
2019
Q4 | $1K | Buy |
+19
| New | +$1K | ﹤0.01% | 1409 |
|